Rush to vaccinate leaves many questions on COVID-19 mRNA vaccines

[truthseeker20]

Recent news were made by Pfizer and Moderna’s vaccine efforts against COVID-19 (or also known as SARS-CoV2) based on their preliminary phase III (3) clinical trial results. Both companies have made their clinical findings in press releases and neither has published complete set of data on these clinical trials in peer-reviewed publications. Shanghai’s Fosun Pharma signed a deal to market BioNTech’s vaccine in China upon eventual approval. Pfizer has agreed with BioNTech to co-develop the vaccine in the rest of the world.

Both Pfizer and Moderna’s vaccine development center on mRNA technology. The rationale behind mRNA-based vaccines is to introduce mRNA sequences (a type of nucleic acid that can translate into proteins) into human body’s cells. The cells then make proteins (in case of COVID-19, its spike or S protein) or antigens to elicit immune response. The use of mRNA vaccines is type of artificially acquired adaptive immunity by means of vaccination. The other primary  means to acquire adaptive or active immunity against pathogens like COVID-19 is by naturally acquired infection and recovery from such infection without any dire medical or health complications.

Both of these candidate mRNA vaccines have no published information on

• the type of acquired immunity that arises in response to mRNA vaccine injections;
• what type of local and systemic immune response are observed in vaccine-injected subjects;
• what are the local and systemic side effects in placebo and mRNA-vaccinated volunteers;
• where is the localization or presence of COVID-19’s spike (S) protein in mRNA vaccine injected individuals at in vivo levels, i.e., is the S protein intracellularly localized, extracellularly located, membrane-bound or been secreted in fluids or extravascular space;
  
• are the expressed S proteins found systemic in other tissues after mRNA vaccine injection and expression.

In the Pfizer and BioNTech collaboration, a self-replicating mRNA vaccine (amplified) nano-particles are used to elicit immune response.

• What is the stability and length of time that mRNAs for spike (S) protein is found in vivo (in cells) with this type of vaccine;
• does auto-immunity or auto-immune disorder develop over time with the mRNA vaccine if expressed antigens (S proteins) stick to other cells in the body that are not immune cells;
• is the robust immune response reported by Pfizer and Moderna represent known immunogenic response against mRNA molecules and not adaptive immune response that would confer protection against future COVID-19 infections or exposures;
• how long does the immune response to COVID-19 last in mRNA-vaccinated subjects.

In both studies, how was protection against subsequent COVID-19 infection measured to determine vaccine efficacy of higher than 90%?

• what methodology was used that led to this conclusion;
• where test subjects under CDC-recommended (wearing masks, physical distancing, hand washing, etc.) or normal (pre-pandemic) real life conditions after vaccination protocols in clinical trial;
• also, did these phase III (3) clinical trials detect any immune system enhancing factors like type I interferon or activation of cell surface, endosomal and cytosolic innate immune receptors in mRNA vaccinated individuals versus placebo;
• finally, how come the previous mRNA vaccines against Zika, influenza, and chikungunya viruses have not completed three phases (I-III) of clinical trials to bring these vaccines to the public.

As you can appreciate, there are more questions than solid answers based on unpublished data or news about prospects of mRNA vaccines from Pfizer and Moderna.  Hence, the rush to get the masses or the public vaccinated, one of the sought goals of the globalists. The lack information about their long-term effects or what is the exact clinical science or data on these novel mRNA vaccines make these vaccines seem dubious.

The masses are the guinea pigs in these unprecedent and unproven mass vaccination experiments!

[Author]

Posts